Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Involvement of estrogen receptor β5 in the progression of glioma
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Involvement of estrogen receptor β5 in the progression of glioma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Estrogen Receptor
100%
Glioma
100%
Hypoxia
50%
Tumor Proliferation
50%
ER Expression
50%
Human Glioma
50%
U87 Cells
50%
Cell Proliferation
25%
Overexpression
25%
Therapeutic Target
25%
Brain Tissue
25%
Protective Mechanism
25%
Tumor
25%
ERK Pathway
25%
ERK MAPK
25%
M Phase
25%
Hypoxia-inducible Factor
25%
Inhibit Tumor
25%
Hypoxic Stress
25%
Reduced Cell
25%
Non-neoplastic
25%
PI3K-AKT-mTOR Pathway
25%
Braking
25%
PTEN Expression
25%
Self-protective
25%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
100%
Tumor Progression
100%
U87
100%
Cell Proliferation
50%
Isoform
50%
Transcription
50%
Cell Cycle M Phase
50%
Hypoxia-Inducible Factors
50%
MAPK/ERK Pathway
50%
PI3K/AKT/mTOR Pathway
50%
Neuroscience
Estrogen Receptor
100%
Cell Proliferation
100%
Cell Cycle M Phase
100%
Hypoxia-Inducible Factors
100%
MAPK/ERK Pathway
100%
PI3K/AKT/mTOR Pathway
100%
Medicine and Dentistry
Ganglioglioma
100%
Estrogen Receptor
100%
Hypoxia
50%
Tumor Progression
33%
U87
33%
Malignant Neoplasm
16%
Cancer
16%
Neoplasm
16%
Cell Proliferation
16%
Hypoxia Inducible Factor
16%
Brain Tissue
16%
Mitogen-Activated Protein Kinase
16%
Cell Cycle M Phase
16%
PI3K/AKT/mTOR Pathway
16%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Hypoxia
100%
Tumor Growth
66%
Malignant Neoplasm
33%
Neoplasm
33%
Hypoxia Inducible Factor
33%
Protein Kinase B
33%